-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Outcomes of Patients with Germline RUNX1 Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis

Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Program: Scientific Workshops
Session: Germline RUNX1-Mediated Disease
Friday, December 6, 2024, 2:02 PM-2:41 PM

Lea Cunningham, MD

National Institutes of Health, Bethesda, MD

Disclosures: No relevant conflicts of interest to declare.

See more of: Germline RUNX1-Mediated Disease
See more of: Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation